https://www.selleckchem.com/pr....oducts/FK-506-(Tacro
5%) patients, and no grade 4-5 RE was reported. The optimal LKB parameters were n = 0.24, m = 0.51, and TD50 = 44.83 Gy (relative biological effectiveness). The optimism-corrected AUC was 0.783, and the Hosmer-Lemeshow test showed significant agreement between predicted and observed morbidity. Bootstrap validation verified that the model was robust to similar future populations. CONCLUSION Our LKB NTCP model to predict grade ≥2 RE in NSCLC patients who received PSPT showed good predictive performance and robustness to simila
إعجاب
علق
شارك
